PUBLIC DISCLOSURE & CLARIFICATION
BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
banner
Composite Nanoparticles
Inquiry

Composite Nanoparticles

Inquiry
Cat. No. Product Name Inquiry
X26-06-ZQ4809 Cyanine 7-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with NGR peptide (PLGA(DOX)-Cy7@NGR)
X26-06-ZQ4812 Cyanine 5.5-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with mannose (PLGA(DOX)-Cy5.5@Mannose)
X26-06-ZQ4813 Cyanine 3.5-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with mannose (PLGA(DOX)-Cy3.5@Mannose)
X26-06-ZQ4814 DBCO-PEG1000-HDA-functionalized gold nanoparticles (DBCO-PEG-HDA@Au NPs)
X26-06-ZQ4815 Cyanine 3-labeled curcumin-loaded PLGA nanoparticles (100 nm size) (PLGA(Cur)-Cy3)
X26-06-ZQ4816 FITC-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with mannose (PLGA(DOX)-FITC@Mannose)
X26-06-ZQ4817 Cyanine 3-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with mannose (PLGA(DOX)-Cy3@Mannose)
X26-06-ZQ4821 Cyanine 5-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with mannose (PLGA(DOX)-Cy5@Mannose)
X26-06-ZQ4822 Rhodamine B-labeled curcumin-loaded PLGA nanoparticles (100 nm size) (PLGA(Cur)-RB)
X26-06-ZQ4823 Cyanine 5-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with NGR peptide (PLGA(DOX)-Cy5@NGR)
X26-06-ZQ4824 Curcumin-loaded PLGA nanoparticles surface-modified with RGD peptide (200 nm size) (PLGA(Cur)@RGD)
X26-06-ZQ4825 FITC-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with NGR peptide (PLGA(DOX)-FITC@NGR)
X26-06-ZQ4827 Cyanine 3.5-labeled curcumin-loaded PLGA nanoparticles (100 nm size) (PLGA(Cur)-Cy3.5)
X26-06-ZQ4828 Rhodamine B-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with NGR peptide (PLGA(DOX)-RB@NGR)
X26-06-ZQ4830 FITC-labeled curcumin-loaded PLGA nanoparticles (100 nm size) (PLGA(Cur)-FITC)
X26-06-ZQ4835 Cyanine 5-labeled curcumin-loaded PLGA nanoparticles (100 nm size) (PLGA(Cur)-Cy5)
X26-06-ZQ4836 Cyanine 5.5-labeled curcumin-loaded PLGA nanoparticles (100 nm size) (PLGA(Cur)-Cy5.5)
X26-06-ZQ4837 Cyanine 3-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with NGR peptide (PLGA(DOX)-Cy3@NGR)
X26-06-ZQ4839 PEG2000-coated barium titanate nanoparticles (PEG2000-BaTiO3 NPs)
X26-06-ZQ4840 Curcumin-loaded PLGA nanoparticles surface-modified with RGD peptide (100 nm) (PLGA(Cur)@RGD)
X26-06-ZQ4841 Indocyanine green-labeled rapamycin-loaded PLGA nanoparticles (PLGA(Rapamycin)-ICG)
X26-06-ZQ4842 Cyanine 5.5-labeled rapamycin-loaded PLGA nanoparticles (PLGA(Rapamycin)-Cy5.5)
X26-06-ZQ4843 Rapamycin-loaded PLGA nanoparticles surface-modified with NGR peptide (PLGA(Rapamycin)@NGR)
X26-06-ZQ4844 Cyanine 5-labeled rapamycin-loaded PLGA nanoparticles (PLGA(Rapamycin)-Cy5)
X26-06-ZQ4845 FITC-labeled SSMDIVLRAPLM peptide-modified doxorubicin-loaded PLGA nanoparticles (PLGA(DOX)@SSMDIVLRAPLM-FITC)
X26-06-ZQ4846 Rapamycin-loaded PLGA nanoparticles surface-modified with chitosan (PLGA(Rapamycin)@Chitosan)
X26-06-ZQ4847 Rapamycin-loaded PLGA nanoparticles surface-modified with metronidazole (PLGA(Rapamycin)@Metronidazole)
X26-06-ZQ4848 Rapamycin-loaded PLGA nanoparticles surface-modified with GE11 peptide (PLGA(Rapamycin)@GE11)
X26-06-ZQ4849 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with Cy3.5 (PLGA@MSNs(DOX)@Cy3.5)
X26-06-ZQ4850 Gold@silver core-shell nanoparticles modified with 4-mercaptobenzoic acid (20 nm Au@Ag@MBA)
X26-06-ZQ4851 Rhodamine B-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with mannose (PLGA(DOX/RB)@Mannose)
X26-06-ZQ4852 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with folic acid (PLGA@MSNs(DOX)@FA)
X26-06-ZQ4853 Rapamycin-loaded PLGA nanoparticles surface-modified with polyethyleneimine (PLGA(Rapamycin)@PEI)
X26-06-ZQ4854 Rapamycin-loaded PLGA nanoparticles surface-modified with SSMDIVLRAPLM peptide (PLGA(Rapamycin)@SSMDIVLRAPLM)
X26-06-ZQ4855 Rapamycin-loaded PLGA nanoparticles surface-modified with glycyrrhetinic acid (PLGA(Rapamycin)@GA)
X26-06-ZQ4856 Cyanine 3-labeled rapamycin-loaded PLGA nanoparticles (PLGA(Rapamycin)-Cy3)
X26-06-ZQ4857 Rapamycin-loaded PLGA nanoparticles surface-modified with folic acid (PLGA(Rapamycin)@FA)
X26-06-ZQ4858 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with FITC (PLGA@MSNs(DOX)@FITC)
X26-06-ZQ4859 Cyanine 5-labeled SSMDIVLRAPLM peptide-modified doxorubicin-loaded PLGA nanoparticles (PLGA(DOX)@SSMDIVLRAPLM-Cy5)
X26-06-ZQ4860 Rapamycin-loaded PLGA nanoparticles surface-modified with ciprofloxacin (PLGA(Rapamycin)@Ciprofloxacin)
PRODUCTS
Featured Products
Nucleic Acid Drug Delivery Products
GalNAc-L96 intermediate, T1 (Cat#: X24-11-YM010) GalNAc-L96 intermediate, T2 (Cat#: X24-11-YM011) GalNAc-L96 intermediate, T3 (Cat#: X24-11-YM012) GalNAc-L96 intermediate, T4-Amine (Cat#: X24-11-YM014) Tri-GalNAc(OAc)3 Cbz (Cat#: X24-11-YM015) Tri-GalNAc(OAc)3 (Cat#: X24-11-YM016) Tri-GalNAc(OAc)3 TFA (Cat#: X24-11-YM017) GalNAc-L96-OH (Cat#: X24-11-YM018) GalNAc-L96-TEA (Cat#: X24-11-YM019)
Hots Products
N-Glycan
Neu5Gcα(2-6)N-Glycan (Cat#: X23-03-YW036) A2G2 N-Glycan (Cat#: X23-03-YW037) A2G2S2 N-Glycan (Cat#: X23-03-YW038) A2 N-Glycan (Cat#: X23-03-YW039) A2[6]G1 N-Glycan (Cat#: X23-03-YW040) M3 N-Glycan (Cat#: X23-03-YW041) A2[3]G2S1 N-Glycan (Cat#: X23-03-YW042)
O-Glycan
Core 2 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW178) Core 2 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW179) Core 3 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW180) Core 3 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW181) Core 4 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW182) T antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW192) T antigen O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW193) Tn antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW194)
Blood Group and Lewis Antigen
Blood group A trisaccharide (Cat#: XCO0060Q) Blood group B trisaccharide (Cat#: XCO0068Q) Blood group H disaccharide (Cat#: XCO0074Q) Lewis A trisaccharide (Cat#: XCO0079Q) 3'-Sulfated lewis A (Cat#: XCO0080Q) Lewis B tetrasaccharide (Cat#: XCO0083Q) Lewis X trisaccharide (Cat#: XCO0085Q) Lewis Y tetrasaccharide (Cat#: XCO0088Q)
Human Milk Oligosaccharides (HMOs)
Lacto-N-biose (Cat#: XCO0089Q) 2'-Fucosyllactose (Cat#: XCO0091Q) 3-Fucosyllactose (Cat#: XCO0092Q) Lactodifucotetraose (Cat#: XCO0093Q) Lacto-N-triose I (Cat#: XCO0094Q) 3'-Sialyllactose sodium salt (Cat#: XCO0096Q) 6'-Sialyllactose sodium salt (Cat#: XCO0098Q) 3'-Sialyl-3-fucosyllactose (Cat#: XCO0100Q)
Glycosaminoglycans
Heparin amine, MW 27 kDa (Cat#: X22-09-ZQ478) FITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ480) TRITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ481) Biotin-heparin-FITC, MW 18 kDa (Cat#: X22-09-ZQ482) Chondroitin sulfate (dp4) (Cat#: X22-11-ZQ598) Dermatan sulfate (dp12) (Cat#: X22-11-ZQ611) Heparin disaccharide I-A (Cat#: X22-11-ZQ662) Chondroitine sulfate (Cat#: X23-04-XQ1118)
Carbohydrate Conjugates
GalNAcβ(1-4)GlcNAcβ-Sp3-Biotin (Cat#: X22-12-ZQ005) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-Biotin (Cat#: X22-12-ZQ006) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-FITC (Cat#: X22-12-ZQ007) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA (Cat#: X22-12-ZQ008) Glcβ(1-4)GalNAcα-Sp3-Biotin (Cat#: X22-12-ZQ037) Glcβ(1-4)GalNAcα-Sp3-PAA-Biotin (Cat#: X22-12-ZQ038) Glcβ(1-4)GalNAcα-Sp3-PAA-FITC (Cat#: X22-12-ZQ039) Glcβ(1-4)GalNAcα-Sp3-PAA (Cat#: X22-12-ZQ040)
Glycolipids
GlcCer (d18:1/8:0) (Cat#: X23-11-ZQ101) GalCer (d18:1/16:0) (Cat#: X23-11-ZQ112) LacCer (d18:1/8:0) (Cat#: X23-11-ZQ118) Lc3Cer (d18:1/8:0) (Cat#: X23-11-ZQ131) Lc4Cer (d18:1/12:0) (Cat#: X23-11-ZQ146) Sialyl-Lc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ162) Lewis a Cer (d18:1/16:0) (Cat#: X23-11-ZQ175) nLc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ190)
Cyclodextrin
Methyl-γ-cyclodextrin (DS 12) (Cat#: X23-11-YM119) Carboxymethyl-ɑ-cyclodextrin sodium salt (Cat#: X23-11-B003) Carboxymethyl-γ-cyclodextrin sodium salt (Cat#: X23-11-B004) Succinyl-ɑ-cyclodextrin (Cat#: X23-11-B005) Succinyl-γ-cyclodextrin (Cat#: X23-11-B006) ɑ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B007) β-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B008) γ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B009)
Dextran
Lysine-dextran, MW 4 kDa (Cat#: X22-09-ZQ273) Phenyl-dextran, MW 150 kDa (Cat#: X22-09-ZQ279) FITC-Q-dextran, MW 10 kDa (Cat#: X22-09-ZQ280) FITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ283) TRITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ287) FITC-dextran sulfate, MW 10 kDa (Cat#: X22-09-ZQ291) Dextran amine, MW 20 kDa (Cat#: X22-09-ZQ377) TRITC-dextran, MW 40 kDa (Cat#: X22-09-ZQ383) Biotin-dextran-FITC, MW 20 kDa (Cat#: X22-09-ZQ389)
Online Inquiry

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Important Links

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.